ReviewInternational journal of molecular sciences2026
Targeting the NLRP3 Inflammasome with Colchicine in COVID-19: Therapeutic Evidence and Future Implications for Influenza.
Vanyo MitevPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.